Literature DB >> 11340362

Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia.

K Imai1, S Harada, Y Kawanishi, H Tachikawa, T Okubo, T Suzuki.   

Abstract

The human synapsin III gene, located on chromosome 22q12-13, has previously been reported to indicate a susceptibility for schizophrenia. Noval rare variants (Thr136Thr in exon 3, Pro468Ser, Glu525Gln and Pro534Leu in exon 12, and 1769 G/C in the untranslated region of exon 13) were found in addition to the polymorphic variant (-196 G/A in the promoter region). No significant differences in genotypic or allelic frequencies of the -196 G/A polymorphism were found between 87 unrelated schizophrenic patients and 100 healthy controls, even when the patients were diagnostically subdivided into subtypes and course specifiers. Furthermore, allelic frequencies of the GATG repeat in intron 1 were not significantly different between the patients and the controls. These results suggest that synapsin III gene polymorphisms are not associated with schizophrenia. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340362     DOI: 10.1159/000054896

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

Review 1.  Synapsin III: role in neuronal plasticity and disease.

Authors:  Barbara Porton; William C Wetsel; Hung-Teh Kao
Journal:  Semin Cell Dev Biol       Date:  2011-07-30       Impact factor: 7.727

2.  Association and expression study of synapsin III and schizophrenia.

Authors:  Qi Chen; Rongling Che; Xu Wang; Francis A O'Neill; Dermot Walsh; Wei Tang; Yongyong Shi; Lin He; Kenneth S Kendler; Xiangning Chen
Journal:  Neurosci Lett       Date:  2009-09-19       Impact factor: 3.046

3.  DNA methylation and mRNA expression of SYN III, a candidate gene for schizophrenia.

Authors:  Brenda C Murphy; Richard L O'Reilly; Shiva M Singh
Journal:  BMC Med Genet       Date:  2008-12-22       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.